263 related articles for article (PubMed ID: 26685481)
1. [Periostin in the Pathogenesis of Proliferative Vitreoretinopathy].
Ishikawa K
Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):772-80. PubMed ID: 26685481
[TBL] [Abstract][Full Text] [Related]
2. Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy.
Ishikawa K; Yoshida S; Nakao S; Nakama T; Kita T; Asato R; Sassa Y; Arita R; Miyazaki M; Enaida H; Oshima Y; Murakami N; Niiro H; Ono J; Matsuda A; Goto Y; Akashi K; Izuhara K; Kudo A; Kono T; Hafezi-Moghadam A; Ishibashi T
FASEB J; 2014 Jan; 28(1):131-42. PubMed ID: 24022401
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy.
Ishikawa K; He S; Terasaki H; Nazari H; Zhang H; Spee C; Kannan R; Hinton DR
Sci Rep; 2015 Nov; 5():16386. PubMed ID: 26552368
[TBL] [Abstract][Full Text] [Related]
4. Periostin in vitreoretinal diseases.
Yoshida S; Nakama T; Ishikawa K; Nakao S; Sonoda KH; Ishibashi T
Cell Mol Life Sci; 2017 Dec; 74(23):4329-4337. PubMed ID: 28913545
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy.
Zhang Y; Zhao D; Yang S; Yao H; Li M; Zhao C; Zhang J; Xu GT; Li H; Wang F
Cell Physiol Biochem; 2018; 46(4):1704-1715. PubMed ID: 29698960
[TBL] [Abstract][Full Text] [Related]
6. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
[TBL] [Abstract][Full Text] [Related]
7. Role of retinal pigment epithelial cell β-catenin signaling in experimental proliferative vitreoretinopathy.
Umazume K; Tsukahara R; Liu L; Fernandez de Castro JP; McDonald K; Kaplan HJ; Tamiya S
Am J Pathol; 2014 May; 184(5):1419-28. PubMed ID: 24656918
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy.
Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC
Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 6 (BMP6) antagonises experimental proliferative vitreoretinopathy established by TGF-β2 stimulation in retinal pigment epithelial cells through modulation of the p38 and JNK MAPK pathways.
Liu X; Liu M; Chen L
Cell Tissue Res; 2024 Apr; 396(1):103-117. PubMed ID: 38403744
[TBL] [Abstract][Full Text] [Related]
10. Effects of Curcumin on Epidermal Growth Factor in Proliferative Vitreoretinopathy.
Ren YX; Ma JX; Zhao F; An JB; Geng YX; Liu LY
Cell Physiol Biochem; 2018; 47(5):2136-2146. PubMed ID: 29975931
[TBL] [Abstract][Full Text] [Related]
11. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study.
Begum G; O'Neill J; Chaudhary R; Blachford K; Snead DRJ; Berry M; Scott RAH; Logan A; Blanch RJ
Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4929-4936. PubMed ID: 30347087
[TBL] [Abstract][Full Text] [Related]
12. Yes-associated protein is essential for proliferative vitreoretinopathy development via the epithelial-mesenchymal transition in retinal pigment epithelial fibrosis.
Zhang W; Li J
J Cell Mol Med; 2021 Nov; 25(21):10213-10223. PubMed ID: 34598306
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy.
He S; Barron E; Ishikawa K; Nazari Khanamiri H; Spee C; Zhou P; Kase S; Wang Z; Dustin LD; Hinton DR
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5579-89. PubMed ID: 26305530
[TBL] [Abstract][Full Text] [Related]
15. Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E.
Wang Y; Yuan Z; You C; Han J; Li H; Zhang Z; Yan H
BMC Ophthalmol; 2014 Nov; 14():144. PubMed ID: 25421815
[TBL] [Abstract][Full Text] [Related]
16. KRT8 phosphorylation regulates the epithelial-mesenchymal transition in retinal pigment epithelial cells through autophagy modulation.
Miao Q; Xu Y; Yin H; Zhang H; Ye J
J Cell Mol Med; 2020 Mar; 24(5):3217-3228. PubMed ID: 32022439
[TBL] [Abstract][Full Text] [Related]
17. Notch signaling modulates proliferative vitreoretinopathy via regulating retinal pigment epithelial-to-mesenchymal transition.
Zhang J; Yuan G; Dong M; Zhang T; Hua G; Zhou Q; Shi W
Histochem Cell Biol; 2017 Mar; 147(3):367-375. PubMed ID: 27600720
[TBL] [Abstract][Full Text] [Related]
18. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid suppresses the adhesion and migration of human retinal pigment epithelial cells.
Du YH; Hirooka K; Miyamoto O; Bao YQ; Zhang B; An JB; Ma JX
Exp Eye Res; 2013 Apr; 109():22-30. PubMed ID: 23428742
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.
Yao J; Hu LL; Li XM; Shan K; Zhou RM; Ge HM; Yao MD; Jiang Q; Zhao C; Yan B
Biomed Pharmacother; 2019 Mar; 111():548-554. PubMed ID: 30597308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
